Sakamuri Reddy to Bone Resorption
This is a "connection" page, showing publications Sakamuri Reddy has written about Bone Resorption.
Connection Strength
2.742
-
Inhibition of NFAM1 suppresses phospho-SAPK/JNK signaling during osteoclast differentiation and bone resorption. J Cell Biochem. 2021 10; 122(10):1534-1543.
Score: 0.745
-
Proteasome inhibition suppress microgravity elevated RANK signaling during osteoclast differentiation. Cytokine. 2020 01; 125:154821.
Score: 0.655
-
Functional characterization of human osteoclast inhibitory peptide-1 (OIP-1/hSca) gene promoter. Gene. 2006 Apr 12; 371(1):16-24.
Score: 0.254
-
Sphingosine-1-Phosphate Receptor 2 Controls Podosome Components Induced by RANKL Affecting Osteoclastogenesis and Bone Resorption. Cells. 2019 01 01; 8(1).
Score: 0.157
-
Autoregulation of RANK ligand in oral squamous cell carcinoma tumor cells. J Cell Physiol. 2018 08; 233(8):6125-6134.
Score: 0.148
-
NFAM1 signaling enhances osteoclast formation and bone resorption activity in Paget's disease of bone. Bone. 2017 Aug; 101:236-244.
Score: 0.140
-
Microgravity control of autophagy modulates osteoclastogenesis. Bone. 2014 Apr; 61:125-31.
Score: 0.111
-
Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bone. Endocrinology. 2011 Nov; 152(11):4180-9.
Score: 0.094
-
Microarray profile of gene expression during osteoclast differentiation in modelled microgravity. J Cell Biochem. 2010 Dec 01; 111(5):1179-87.
Score: 0.089
-
Osteoclast inhibitory peptide-1 (OIP-1) inhibits measles virus nucleocapsid protein stimulated osteoclast formation/activity. J Cell Biochem. 2008 Jul 01; 104(4):1500-8.
Score: 0.076
-
Activation of NFAT signal in vivo leads to osteopenia associated with increased osteoclastogenesis and bone-resorbing activity. J Immunol. 2006 Aug 15; 177(4):2384-90.
Score: 0.066
-
Etiologic factors in Paget's disease of bone. Cell Mol Life Sci. 2006 Feb; 63(4):391-8.
Score: 0.064
-
(23S)-25-Dehydro-1{alpha}-hydroxyvitamin D3-26,23-lactone, a vitamin D receptor antagonist that inhibits osteoclast formation and bone resorption in bone marrow cultures from patients with Paget's disease. Endocrinology. 2005 Apr; 146(4):2023-30.
Score: 0.059
-
Regulatory mechanisms operative in osteoclasts. Crit Rev Eukaryot Gene Expr. 2004; 14(4):255-70.
Score: 0.055
-
Vitamin D antagonist, TEI-9647, inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D3 from pagetic bone marrow cells. J Steroid Biochem Mol Biol. 2004 May; 89-90(1-5):331-4.
Score: 0.014
-
Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's Disease. J Bone Miner Res. 2004 Jul; 19(7):1154-64.
Score: 0.014